REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemia cases: gentler treatment trial opens for elderly
Disease control Recruiting nowThis study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin) with lower-intensity chemotherapy and immunotherapy for adults with a type of blood cancer called acute lymphoblastic leukemia (ALL). It focuses on patients aged 60 and older, or younger adults …
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 21:11 UTC
-
New Two-Pronged attack tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing a two-step treatment for a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). It is for older adults who are newly diagnosed or for adults whose cancer has come back or hasn't responded to other treatments. The treatment first uses a targ…
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Targeted missile drug tested in kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a drug called inotuzumab ozogamicin for children and young adults whose B-cell leukemia has come back or hasn't responded to other treatments. The drug is designed to find and kill only the cancer cells. Researchers want to see how well it works and how safe…
Matched conditions: REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC